immunity News and Research

RSS

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Research demonstrates within-host seasonal immunity

Researchers investigate the association between seasonal flu changes and gene expression to determine the ‘within-host’ immunity concept.

17 Mar 2022

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

Scientists evaluate the humoral and cellular immune responses in individuals who have received a third booster dose of mRNA-based COVID-19 vaccine.

17 Mar 2022

Hispanic/Latino youth with food insecurity have worse cardiometabolic profiles, study shows

Hispanic/Latino youths with limited access to nutritionally adequate food – and especially those whose parents were foreign-born -- had worse cardiometabolic profiles than their "food secure" counterparts, according to a study published in Pediatrics.

17 Mar 2022

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers studied the immune responses in Syrian hamsters re-infected with SARS-CoV-2 Delta and B.1 variants three months after the primary infection.

17 Mar 2022

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Researchers evaluated biomarkers that could help identify COVID-19 patients needing invasive mechanical ventilation.

17 Mar 2022

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Researchers compared the efficacy of booster doses of heterologous intramuscular and aerosolized adenovirus-vectored vaccine, a recombinant protein-based ZF2001 vaccine, and homologous CoronaVac vaccines.

17 Mar 2022

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

A new study discussed the impact of COVID-19 measures on the future transmission of the respiratory syncytial virus in South Africa.

17 Mar 2022

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Researchers assessed the safety profile and immunogenicity of a heterologous NVSI-06-08 boost against SARS-CoV-2 variants in individuals doubly vaccinated with the inactivated vaccine BBIBP-CorV.

17 Mar 2022

Frail and older males more vulnerable to COVID-19 than females

Researchers evaluated the association of biological sex, frailty, and age with the vaccine-elicited immunity against SARS-CoV-2.

17 Mar 2022

Study suggests expanding vaccination to children aged 5-11 would provide benefits to the US population

Researchers evaluated the impact of immunizing five-11-year-old children against SARS-CoV-2 on COVID-19 burden and resilience to new variants in the United States.

17 Mar 2022

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

An inhalable 'aerogel' loaded with DNA that encodes for the SARS-CoV-2 spike protein successfully induces an immune response against COVID-19 in the lungs of mice, according to new research conducted at Penn State.

16 Mar 2022

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

Income loss was a strong predictor of menstrual product insecurity across the U.S. during COVID-19, and populations with lower incomes and the lowest educational attainment were most vulnerable, according to a new study conducted by Columbia University Mailman School of Public Health in partnership with the CUNY School of Public Health.

16 Mar 2022

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

While many people in wealthier countries have been vaccinated against Covid-19, there is still a need for vaccination in much of the world.

16 Mar 2022

Study finds a promising new target for immunity-boosting cancer treatments

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.

16 Mar 2022

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine.

16 Mar 2022

immunity News and Research

Impact of new COVID vaccinations as novel variants emerge

Research demonstrates within-host seasonal immunity

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

Hispanic/Latino youth with food insecurity have worse cardiometabolic profiles, study shows

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Frail and older males more vulnerable to COVID-19 than females

Study suggests expanding vaccination to children aged 5-11 would provide benefits to the US population

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

Study finds a promising new target for immunity-boosting cancer treatments

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

New insight into how gut bacteria work to counter intestinal inflammation

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News